HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy.

AbstractBACKGROUND:
Cardiac fibrosis is a hallmark of hypertrophic cardiomyopathy (HCM) and has confirmed unfavorable clinical significance. Replacement fibrosis is better known and has already been studied on a larger scale, whereas interstitial fibrosis is less explored.
AIMS:
We aimed to analyze the relationship between serum biomarkers and interstitial fibrosis, as assessed with cardiac magnetic resonance (CMR) in HCM patients.
METHODS:
We performed 3T CMR scans in 50 HCM patients to assess interstitial fibrosis as expressed by extracellular volume (ECV). In all patients, we determined levels of serum cardiac-specific (troponin T [TnT], N-terminal prohormone of brain natriuretic peptide [NT-proBNP]) and fibrosis-specific (procollagen I C-terminal propeptide, procollagen III N-terminal propeptide, transforming growth factor β1, galectin-3) biomarkers. Patients were divided based on their median value of ECV.
RESULTS:
The final study population included 49 patients. The median value of ECV in our cohort was 28.1%. Patients stratified according to median ECV differed in terms of several variables: body mass index, late gadolinium extent, NT-proBNP, and galectin-3 levels (all P <0.05). Cardiac biomarkers (TnT and NT-proBNP) and galectin-3 were significantly correlated with ECV (rS = 0.34; P = 0.02; rS = 0.39; P = 0.006; rS = 0.43; P = 0.002, respectively). Galectin-3 and body mass index were found to be independent predictors of ECV (odds ratio [OR], 2.29 [1.07-4.91]; P = 0.03; OR, 0.81 [0.68-0.97]; P = 0.02, respectively).
CONCLUSIONS:
Galectin-3 was an independent predictor of interstitial fibrosis in HCM patients expressed as elevated ECV values. The other measured fibrosis-specific biomarkers were not useful in detecting interstitial fibrosis in HCM. In addition, there was a positive correlation between classical cardiac biomarkers and interstitial fibrosis in HCM patients.
AuthorsAleksandra Karabinowska-Małocha, Ewa Dziewięcka, Magdalena Szymańska, Paweł Banyś, Małgorzata Urbańczyk-Zawadzka, Maciej Krupiński, Małgorzata Mielnik, Sylwia Wiśniowska-Śmiałek, Piotr Podolec, Aleksandra Budkiewicz, Łukasz Żydzik, Ewa Wypasek, Paweł Rubiś
JournalKardiologia polska (Kardiol Pol) Vol. 81 Issue 7-8 Pg. 692-699 ( 2023) ISSN: 1897-4279 [Electronic] Poland
PMID37431248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Galectin 3
  • Procollagen
  • Biomarkers
  • Contrast Media
Topics
  • Humans
  • Galectin 3
  • Procollagen
  • Cardiomyopathy, Hypertrophic (diagnosis)
  • Biomarkers
  • Fibrosis
  • Myocardium (pathology)
  • Contrast Media
  • Predictive Value of Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: